# Endovascular Treatment With Versus Without Intravenous rhTNK-tPA in Stroke

> **NCT04733742** · PHASE2,PHASE3 · COMPLETED · sponsor: **Xinqiao Hospital of Chongqing** · enrollment: 550 (actual)

## Conditions studied

- Stroke, Acute
- Stroke, Ischemic

## Interventions

- **DRUG:** rhTNK-tPA
- **OTHER:** Endovascular treatment

## Key facts

- **NCT ID:** NCT04733742
- **Lead sponsor:** Xinqiao Hospital of Chongqing
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-05-09
- **Primary completion:** 2024-12-16
- **Final completion:** 2025-02-07
- **Target enrollment:** 550 (ACTUAL)
- **Last updated:** 2025-04-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04733742

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04733742, "Endovascular Treatment With Versus Without Intravenous rhTNK-tPA in Stroke". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04733742. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*